Monthly Archives: August 2019

LOOP Insights Provides Details on the Announced Private Placement

VANCOUVER, BC / ACCESSWIRE / August 29, 2019 / LOOP Insights Inc. (TSXV:MTRX) (the “Company” or “Loop”) today announces the rationale behind the non-brokered private placement at a price of $0.28 per unit for gross proceeds of up to $1M announced yesterday.

The Company’s original intention was to do a larger raise later in the Fall of 2019 as it anticipated substantial operational increases in order to put the support and management systems in place to meet the needs of several large-scale projects the Company has been engaged in. As discussions with two major business entities have progressed into proof-of-concept stage much earlier than anticipated, the Company has realized some of the investments into infrastructure need to be put in place sooner.

Loop’s potential partners have commenced their thorough due diligence on the Company. Part of due diligence is showing Loop’s ability to scale to the partners’ long-term business needs. The Company needs to add to its front-end support and tech development teams as well as additional back-end resources. There are several software management platforms that Loop will need to license and add to its support systems immediately. These licenses will have substantial upfront costs in order to start integration as soon as possible.

All of the above-mentioned means significant additional operational expenses, which originally weren’t expected until later in Q4. Therefore, Loop’s Management decided to initiate a small private placement offering to raise resources needed in due diligence requirements that will ultimately keep the Company in a place of strength and fuel the growth opportunities at hand.

Rob Anson, Founder & CEO of Loop, says: “While we understand that the timing of the placement is not ideal, management is trying to be proactive in putting these resources together to support the business opportunities Loop has been engaged in. This will give our large customers confidence in Loop’s ability to support their needs while presenting exceptional market growth opportunities for the Company.”

About LOOP

LOOP Insights Inc. (TSXV:MTRX) is a Vancouver-based technology company that has developed a unique automated AI marketing platform that intends to level the playing field for brick and mortar retailers in their battle with online digital competition. LOOP gives brands and retailers the capability to inter-connect their physical and digital ecosystems by using the device that can be plugged into any point of sale environment, independent of hardware or IT networks, thus enabling rapid deployment and global scale. Retailers and brands benefit from making real-time, data-driven decisions that help them curate unique personalized customer experiences in stores, a capability which previously did not exist.

For more information, please contact:

LOOP Insights Inc.
Soy Garipoglu, Manager, IR
T: 778-990-8985
E: ir@loopinsights.ca

CHF Capital Markets
Cathy Hume, CEO
T: 416-868-1079 x 231
E: cathy@chfir.com

LOOP Website: www.loopinsights.ai
Facebook: @LoopInsights
Twitter: @LoopInsights
LinkedIn: @LoopInsights

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: LOOP Insights Inc.

ReleaseID: 557933

Theralase Releases Second Quarter 2019 Financial Results and Company Update

TORONTO, ON / ACCESSWIRE / August 29, 2019 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers, today released financial results and the Management Discussion and Analysis (“MD&A”) at and for the six-months period ended June 30, 2019.

Financial Highlights:

Condensed Consolidated Statements of Operations (Unaudited)

Three-Month Ended June 30

Six-Month Ended June 30

In Canadian Dollars

2019

2018

2019

2018

Total Revenues

$
249,257

$
469,497

$
370,436

$
910,690

Cost of sales

$
183,393

$
189,464

$
267,644

$
432,321

Gross margin

$
65,864

$
280,033

$
102,792

$
478,369

As percentage of revenue

26
%

60
%

28
%

47
%

Net loss

$
(1,486,797
)

$
(885,283
)

$
(2,612,268
)

$
(1,889,351
)

Loss per share

$
(0.01
)

$
(0.01
)

$
(0.02
)

$
(0.01
)

Total revenue for the six-month period ended June 30, 2019 decreased to $370,437 from $910,690 for the same period in 2018, a 59% decrease. The decrease in total revenue in 2019 is due to the restructuring of the sales and marketing departments resulting in the termination of certain sales and marketing personnel.

Cost of sales for the six-month period ended June 30, 2019 was $267,644 (72% of revenue) resulting in a gross margin of $102,792 or 28% of revenue, compared to a cost of sales of $432,321 (47% of revenue) in 2018, resulting in a gross margin of $478,369 or 53% of revenue. The gross margin as a percentage of sales decrease, year over year, is attributed to decreased sales and fixed production salaries for the TLC-1000 and TLC-2000 product lines.

For the six-month period ended June 30, 2019, selling and marketing expenses decreased to $344,501 or 93% of sales, from $499,204 or 55% of sales in 2018, a 31% decrease. The decrease in selling and marketing expenses is primarily due to the restructuring of the Canadian and US sales and marketing departments, resulting in the termination of certain sales and marketing personnel.

Administrative expenses for the six-month period ended June 30, 2019 decreased to $1,062,087 from $1,143,191 in 2018, representing a 7% decrease. Decreases in administrative expenses are attributed to the decreased spending on professional fees (61%) due to reduced spending on legal fees as a result of the OSC settlement.

Research and development expenses for the six-month period ended June 30, 2019 increased to $1,303,375 from $730,104 in 2018, a 79% increase. The increase is primarily due to increased expenses for commencing Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) Clinical Study (“Study II”) . Research and development expenses represented 50% of the Company’s operating expenses for the six-month period ended June 30, 2019 and represent investment into the research and development of the Company’s Anti-Cancer Technology (“ACT”).

The net loss for the six-month period ended June 30, 2019 was $2,612,268 which included $187,941 of net non-cash expenses (i.e.: amortization, stock-based compensation expense, foreign exchange gain/loss and lease inducements). This compared to a net loss for the same period in 2018 of $1,889,351, which included $155,265 of net non-cash expenses.

The ACT division represented $1,459,713 of this loss (56%) for the six-month period ended June 30, 2019. The increase in net loss is primarily attributed to the following:

Increased investment in research and development in the NMIBC Study II.

Decreased sales of the TLC-1000 and TLC-2000.

Operational Highlights:

Oversubscribed Prospectus Offering. The Company has successfully completed an oversubscribed marketed public offering (“Offering”) on August 22, 2019, raising gross proceeds of CAD $17,250,000. Use of proceeds of the Offering are intended for: advancing the NMIBC Study II, optimization of the TLC-2000 therapeutic laser system, working capital and general business purposes.

Successful Phase Ib NMIBC Clinical Study. Theralase’s Phase Ib NMIBC clinical study successfully achieved the primary endpoint of safety and tolerability, secondary endpoint of pharmacokinetics, and exploratory endpoint of efficacy. The study results have shown a strong efficacy signal with a 66% Complete Response (“CR”) in the Therapeutic Dose Group (0.70 mg/cm2) after only a single PhotoDynamic Therapy (“PDT”) treatment, with patients five and six demonstrating cancer-free status with no presence, recurrence or progression of the disease, 360 days post treatment. Further, patient five has demonstrated an extended cancer-free status for 18 months post treatment.

Study II Launch. The commencement of Study II is underway with the first patient enrolled and ready to be treated at the Company’s lead study site, University Health Network (“UHN”). Additionally, McGill University Health Centre (“MUHC”) is added as another study site, subject to a Site Initiation Visit (“SIV”) tentatively scheduled for early September, 2019. Through the agreement with the US uro-oncology Trial Management Organization (“TMO”), the Company is planning to onboard up to 6 US based clinical study sites and is diligently working to bring approximately 20 clinical sites on board.

FDA compliance. In June 2019, FDA confirmed in the Pre-Investigational New Drug (“IND”) conference call, that Theralase’s protocol design for Study II is aligned with the industry guidelines (February, 2018) for Bacillus Calmette Guerin (“BCG”)-unresponsive NMIBC.

Shawn Shirazi, Ph.D., CEO of Theralase – Drug Division stated that, “With the first patient soon to be treated, we are very excited to advance our Phase II NMIBC Clinical Study, as it allows the Company to potentially commercialize this groundbreaking technology for patients afflicted with this devastating disease. The Company now has all the characteristics of other successful biotech companies such as: cutting-edge technology, an experienced management team, and sufficient capitalization to successfully execute on the Company’s strategic initiatives.”

Kipton Lade, CEO of Theralase – Device Division stated that, “With the completion of this most recent round of financing, Theralase is poised to accelerate execution on the Company’s key strategic objectives, such as successful completion of Study II and commercialization of our NMIBC anti-cancer technology.”

About Study II:

The Phase II NMIBC Clinical Study will utilize the Therapeutic Dose (0.70 mg/cm2) of TLD-1433, focusing on the treatment of approximately 100 BCG-Unresponsive NMIBC patients presenting with Carcinoma In-Situ (“CIS”) in approximately 20 clinical study sites located in Canada and the US, with a primary endpoint of efficacy (measured by CR) and a secondary endpoint of duration of CR and a tertiary endpoint of safety.

The primary and secondary endpoint will be evaluated by:
CR in patients with CIS with resected papillary disease at any time point post-treatment with a duration of CR evaluated at approximately 360 days post-treatment.

Patient CR is defined as one of the following (no cancer detected in bladder):

Negative cystoscopy and negative (including atypical) urine cytology (no cancer detected in urine)

Positive cystoscopy (cancer detected in bladder) with biopsy-proven benign or low-grade NMIBC

Negative cystoscopy with malignant urine cytology (no cancer detected in urine), if cancer is found in the upper tract or prostatic urethra and random bladder biopsies are negative

The tertiary endpoint will be evaluated by:
Incidence and severity of Adverse Events (“AEs”) Grade 4 or higher that do not resolve within 360 days post-treatment; whereby: Grade 1 = Mild, Grade 2 = Moderate, Grade 3 = Severe, Grade 4 = Life-threatening or disabling, Grade 5 = Death

About Theralase® Technologies Inc.

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Additional information is available at www.theralase.com and www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company’s proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as “may”, “would”, “could”, “should”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to: adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its development plans. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273)
416.699.LASE (5273)

Shushu Feng, Investor Relations & Public Relations Coordinator
sfeng@theralase.com

Amelia Tudo, Investor Relations & Public Relations Coordinator
atudo@theralase.com
www.theralase.com

SOURCE: Theralase Technologies Inc.

ReleaseID: 557934

FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DBD, MNK and VAL

CEDARHURST, NY / ACCESSWIRE / August 29, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

Diebold Nixdorf, Incorporated (NYSE:DBD)

Investors Affected: February 14, 2017 – August 1, 2018

A class action has commenced on behalf of certain shareholders in Diebold Nixdorf, Incorporated. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) as a result of the Wincor acquisition and related integration, the Company was less focused on its core business; (2) the Company expected certain customers would not renew their service contracts (i.e. contract runoff); (3) the Company was not adequately prepared to staff service technicians; (4) as a result of the expected contract runoff, the Company would suffer a shortage of adequately trained service technicians; (5) as a result, the Company would suffer margin pressure in its services segment; (6) as a result of the foregoing, the Company would lose market share; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/diebold-nixdorf-incorporated-loss-submission-form/?id=3263&from=1

Mallinckrodt Public Limited Company (NYSE:MNK)

Investors Affected: February 28, 2018 – July 16, 2019

A class action has commenced on behalf of certain shareholders in Mallinckrodt Public Limited Company. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS; (ii) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://kclasslaw.com/securities/mallinckrodt-public-limited-company-loss-submission-form/?id=3263&from=1

Valaris plc (NYSE:VAL)

Investors Affected: April 11, 2019 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Valaris plc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company’s second quarter 2019 results; (iii) the merger leading to Valaris’s establishment could not deliver on its touted benefits; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://kclasslaw.com/securities/valaris-plc-loss-submission-form/?id=3263&from=1

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967

SOURCE: Kuznicki Law PLLC

ReleaseID: 557931

Continuum Global Solutions Adds Executives To Its Senior Management Team

Global Customer Service Leader Names Rainer Diekmann As Managing Director, Europe And Alvaro Garcia as Managing Director, Latin America As Part Of Company’s Newest Senior-Level Appointments

DALLAS, TX / ACCESSWIRE / August 29, 2019 / Reflecting the company’s continuing expansion in the US and key international markets, Continuum Global Solutions LLC (www.continuumgbl.com) has announced several new additions to its senior management team, led by the appointments of Rainer Diekmann as Managing Director, Europe And Alvaro Garcia as Managing Director, Latin America and Caribbean.

Rainer Diekmann

Diekmann takes the helm of Continuum’s European operations bringing 25 years of sales and management expertise to his new role. Prior to joining Continuum, Rainer was Vice President Germany and the European Portfolio Lead for Telecommunications, Media and Utilities at Conduent, Inc. Rainer was also the Founder and Managing Director of Invoco, an outsourced customer care company, and Managing Director of Walter Services. He graduated from University in Wiesbaden, Germany with a degree in economics.

Alvaro Garcia

Garcia joins Continuum Global Solutions with over two decades of experience in the customer care industry, most recently serving as the Managing Director of South American Operations for Conduent, Inc. and Xerox. Alvaro also held numerous leadership roles at Entel, a multinational telecommunications firm based in Chile. He brings to his new Continuum leadership position a wealth of expertise with a strong understanding of managing telecommunications and contact centers in various Latin America countries including Argentina, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras and Perú. Alvaro holds a Commercial Engineering degree from the Universidad Católica de Chile.

Rochelle Moyer

Also named to the Continuum management team are Ann Harts, who assumes the role of Director of Global Real Estate & Facilities , Rochelle Moyer, who joins the company as Vice President PMO and Compliance; Martii Simpson, who is named Director of Business Solutions; and Michael Dayton who will serve as Vice President of Work Force Management.

Ann Harts

Bringing over 20 years’ experience in site selection, real estate strategy, labor analysis and public incentive advisory, Harts has previously led the global real estate operations for two publicly traded BPO organizations. As a three-time winner of Nearshore America’s Most Influential Executives, she is also an award-winning speaker who has authored numerous articles, and hosted podcasts covering the customer care industry. She was also a co-founder of the LatAm Alliance, and a member of their Board of Directors. She received her bachelor’s degree from Kansas State University and is a graduate of the Economic Development Institute at the University of Oklahoma.

Martii Simpson

Moyer, who will oversee project management, security and special projects as part of her new assignment with Continuum is a seasoned project and program management professional with experience in Lean Six Sigma, process optimization, risk management, operations and strategic planning. Prior to joining Continuum, she served as Implementation Director at Conduent, Inc. where she was responsible for managing a team of project managers. She also held similar program and project manager responsibilities at Xerox. She received her bachelor’s degree from Texas A&M University and her MBA from the University of Rochester Simon School.

Michael Dayton

Simpson joins Continuum with over 25 years of experience working in business process outsourcing, customer care and telecommunications. In addition to growing the footprint of the business, she oversees contract administration and requests for proposals. With a strong knowledge of business operation and business development including revenue forecasting, budgeting and margin improvement, she has been responsible for managing high profile, high visibility clients across large multi-national enterprises. Simpson has a BS Mathematics/Actuarial Science from Slippery Rock University and an MBA from Frostburg State University.

In his new position with Continuum, Dayton be responsible for the strategic direction and tactical guidance for capacity planning, real-time management, intra-day analysis, forecasting and scheduling at Continuum’s 34 sites around the world. Dayton joins Continuum with more than 25 years of experience in contact center industry workforce management, operations and technology. He previously served as Vice President of Workforce Management for LPL Financial, the largest independent broker-dealer in the United States. Earlier in his career Michael held workforce leadership positions at Accenture, Hyundai Capital, PSCU Financial, Toyota Financial Services, Experian, Adelphia, Airtouch and People Support. Dayton is a member of the Society of Workforce Management Professionals, Workforce Management Software Group, International Call Center Group and Workforce Management Consultant Group. He received a BS in Management from Hayward University.

“As Continuum Global Solutions continues its commitment towards delivering to clients the highest levels of excellence, we are proud to attract senior-level executives that bring to the company unparalleled customer care expertise and outstanding track records of success. Together with our exciting new management team, we look forward to further serving the industry as a trend-setting industry leader,” said Jerry Kinnick, President, President of Continuum Global Solutions.

About Continuum Global Solutions, LLC: Headquartered in Dallas, Continuum Global Solutions “CGS” customer care services and call centers have been embraced by top companies worldwide. The company’s Fortune-500 clients rely on its expertise in customer care management. CGS customer care and call center solutions leverage world class voice, chat, email, and social technologies. Continuum has more than 15,000 employees in major international markets and serves tier-1 clients across multiple industry verticals. More information can be found at www.continuumgbl.com.

About Skyview Capital, LLC: Parent of Continuum Global Solutions, Skyview Capital, LLC is a global private investment firm headquartered in Los Angeles, California, that specializes in the acquisition and management of mission critical enterprises in the areas of technology, telecommunications, business services and niche manufacturing. By leveraging its operational capabilities and financial acumen, Skyview systematically enhances the long-term sustainable value of the businesses it acquires. The Los Angeles Business Journal recently recognized Skyview as one of the top 25 private equity firms in Los Angeles. To date, Skyview has successfully completed over 25 transactions within its target market verticals. For further information, please visit www.skyviewcapital.com.

CONTACT:
Steve Syatt
SSA Public Relations
steve@ssapr.com
(818) 222-4000

SOURCE: SSA Public Relations

ReleaseID: 557877

SharpSpring’s New Meetings Feature Brings Hassle-Free Scheduling to Marketing Automation

GAINESVILLE, FL / ACCESSWIRE / August 29, 2019 / SharpSpring, Inc. (NASDAQ: SHSP), a leading cloud-based marketing automation platform, today announced the release of Meetings, a fully integrated calendar tool for individuals and sales teams built to streamline scheduling and increase conversions.

Meetings allows prospects to self-schedule appointments – eliminating the unproductive “what time is good for you” dialogue – all while leveraging the power of marketing automation to amplify the impact of every sales meeting.

“Meetings combines the convenience of an enhanced booking calendar with the end-to-end ROI of a full-featured marketing automation platform,” said Morgan Bell, Director of Product at SharpSpring. “Meetings not only boosts production by increasing the total number of personal interactions your team can have each week, but it’s also designed to convert those conversations into sales. You just can’t do this with a standalone calendar app. ”

The release comes with functionality that sales teams expect, like automatic confirmation and reminder emails, but it’s the integration with SharpSpring’s automation engine that allows booked meetings to adjust lead scores, trigger a series of follow-up tasks, or kick off a nurture drip. Meetings interacts with SharpSpring’s Task Manager, Visual Workflow Builder, Life of the Lead and more, bringing a truly integrated approach to sales and marketing.

The release of Meetings also introduces a native Zoom integration, making it seamless for users to host virtual meetings, too. Zoom Meetings provide HD video, audio, and content sharing across all devices.

And while SharpSpring has always paired well with scheduling tools like Calendly and YouCanBook.Me, having the functionality now embedded into the platform at no extra cost has customers excited about its potential.

“I’ve been networking for over a decade, and the back-and-forth emails to schedule a simple coffee meeting or video call can be grueling,” said SharpSpring partner Jason Kramer, CEO of Cultivize. “While the invention of calendar booking apps made this process more efficient, having the new Meetings feature built into SharpSpring for free has made booking meetings easier and more effective. Plus, it eliminates the cost for a third-party app, which is always a win.”

This robust new functionality, combined with SharpSpring’s recent release of Sales Optimizer and the upcoming release of Sales Dialer, promises an exciting new value-add for users. SharpSpring remains one of the only fully integrated marketing and sales platforms available today that focuses on the success of growing small businesses and marketing agencies.

To learn more about SharpSpring, visit sharpspring.com.

About SharpSpring, Inc.

SharpSpring, Inc. (NASDAQ:SHSP) is a rapidly growing, highly-rated global provider of affordable marketing automation delivered via a cloud-based Software-as-a-Service (SaaS) Platform. Thousands of businesses around the world rely on SharpSpring to generate leads, improve conversions to sales, and drive higher returns on marketing investments. Known for its innovation, open architecture and free customer support, SharpSpring offers flexible monthly contracts at a fraction of the price of competitors making it an easy choice for growing businesses and digital marketing agencies. Learn more at sharpspring.com.

Company Contact:

Brad Stanczak
Chief Financial Officer
Phone: 352-448-0967
Email: IR@sharpspring.com

Investor Relations:

Gateway Investor Relations
Matt Glover or Tom Colton
Phone: 949-574-3860
Email: SHSP@gatewayir.com

SOURCE: SharpSpring, Inc.

ReleaseID: 557910

SeaChange International Reports Second Quarter Fiscal 2020 Results

Revenue Increases by 58% as Framework Offering Gains Traction

Management Reiterates Full Year Guidance

Yossi Aloni Named Chief Executive Officer

ACTON, MA / ACCESSWIRE / August 29, 2019 / SeaChange International, Inc. (NASDAQ:SEAC) today reported second quarter fiscal 2020 revenue of $18.8 million and a net loss of $0.2 million, or $0.00 per basic share, compared to second quarter fiscal 2019 revenue of $11.9 million and a net loss of $9.1 million, or $0.26 per basic share.

Quarterly and Recent Highlights

Announced the release of the Framework 7th generation Backoffice, a major milestone for this product family. This critical element of the Framework solution is significantly re-architected for ease of deployment and maintenance for the Framework customers. Also released Orchestrator and Analytics engines, which are critical value-adding components of the Framework.
Won seven customers since the beginning of the fiscal year covering multi-year commitments for the Framework video delivery platform amounting to more than $20 million in total deal value.
Ended the quarter with $16 million in backlog, an increase of $5 million, or 45%, from April 30, 2019.
Recorded $18.8 million of revenue with the majority from Framework deals.
Recorded nearly break-even net earnings on a GAAP basis and non-GAAP operating income of $1.0 million in the quarter.
Initiated a share repurchase program in June; purchased 100,000 shares for a total consideration of approximately $140,000 in the quarter.

Today SeaChange is also announcing that effective immediately, Yossi Aloni, has been appointed President and Chief Executive Officer of the Company. Mr. Aloni, who joined SeaChange in January 2019 as Chief Commercial Officer, strategized, developed and implemented the Framework solution and Go-to-Market strategy that is responsible for the Company’s recent growth. Chad Hassler, who has served as Head of North American Sales, has been named Chief Commercial Officer; Mr. Hassler joined SeaChange earlier this year and brings more than 20 years of experience in sales and marketing in the video delivery domain to the Company.

Mark J. Bonney, Executive Chairman said, “We are very pleased with our achievements in the second quarter. The number of Framework deals closed and in the pipeline is solid evidence that the strategy of offering an end-to-end video delivery platform is working. Revenues, mainly from the Framework deals, along with the benefits of the consolidation of our R&D resources in Warsaw, which produced the Backoffice 7th generation in one year, and our continual focus on every element of cost in the business allowed us to achieve non-GAAP operating profitability in the second quarter and earlier than previously expected.” Mr. Bonney added, “I congratulate Yossi on his appointment, which reflects the entire Board’s confidence in his ability to step up to the Chief Executive Officer role and lead SeaChange going forward.”

Yossi Aloni, Chief Executive Officer, commented, “I thank the Board for showing their confidence in me and I look forward to leading SeaChange as CEO during these exciting times for the Company and the industry”. Mr. Aloni added “I am pleased with our Framework wins in the first half of this year. In the second quarter we began to recognize revenue from some of the customers who have adopted our solution. Based upon our expanding engagement with new and existing customers, we continue to expect transactions involving the Framework solution to increase materially in the back half of the year, in line with our annual guidance. With our results in the first half of this fiscal year, and the second quarter particularly, we remain confident about our ability to achieve our annual revenue guidance.”

The Company’s U.S. GAAP second quarter fiscal 2020 results included charges of $1.7 million used in non-GAAP calculations, which consisted of amortization of intangible assets from prior acquisitions of $0.3 million, severance and other restructuring costs of $0.7 million, stock-based compensation of $0.6 million and professional fees of $0.1 million. Second quarter fiscal 2019 results included charges of $1.9 million used in non-GAAP calculations, which consisted of stock-based compensation of $0.9 million, amortization of intangible assets from prior acquisitions of $0.4 million and severance and other restructuring costs of $0.5 million. Non-GAAP income from operations in the second quarter of fiscal 2020 was $1.0 million, or $0.03 per fully diluted share, compared to a non-GAAP net loss from operations in the second quarter of fiscal 2019 of $6.4 million, or $0.18 per basic share.

For the first six months of fiscal 2020, the Company reported revenue of $27.3 million and a net loss of $11.0 million, or $0.30 per basic share, compared to revenue of $26.8 million and a net loss of $14.6 million, or $0.41 per basic share in the same period in the prior fiscal year. The non-GAAP loss from operations for the first six months of fiscal 2020 was $6.5 million, or $0.18 per basic share, compared to a non-GAAP loss from operations of $10.2 million, or $0.29 per basic share, in the first half of fiscal 2019.

Outlook

Update on the Company’s key metrics for fiscal 2020:

Goal: Close 20-25 significant deals for multiple product/service offerings on an annual basis. Progress: Closed seven significant deals since the beginning of the fiscal year on February 1, 2019.
Goal: Increase total annual revenue in the low to mid double digits percentage range to $70-80 million, despite lower year-over-year service revenues. Progress: The Company is encouraged by the growth of the Framework deal pipeline and remains confident in the full year revenue target.
Goal: Maintain GAAP gross margins in the low 60 percentage range. Progress: While legacy gross margins resulted in lower overall gross margins in the first half of fiscal 2020, gross margins contributed by the Framework deals in the first half of the fiscal year exceeded 60% and will drive overall gross margins above 60% in the second half of fiscal 2020.
Goal: Complete the development of three significant new product offerings. Progress: With the release of flagship Adrenalin 7.0, along with Orchestrator 1.0 and Analytics 1.0, product development efforts have already achieved this goal.
Goal: Continue to reduce costs by focusing on reducing essential third-party costs and eliminating non-essential costs. Progress: Efforts to reduce third-party costs were significantly achieved in Q2 with full annualized savings impact anticipated beginning in Q3. Work here is continuing as we align the organization with the realities of the business needs as the Framework solution continues to roll out. As a result of these continuing efforts, which are anticipated to be competed in the fourth quarter of this fiscal year, we anticipate significant additional savings in FY 2021.
Goal: Deliver GAAP operating results between a loss of $0.09 per basic share to income of $0.07 per fully diluted share and non-GAAP operating income between $0.03 to $0.19 per fully diluted share. Progress: Management continues to believe this goal can be met for the full year.
Goal: Increase cash by $3-6 million to $28-31 million. Progress: The Company has re-evaluated this goal based on the early Framework deals where payments have been spread over time as opposed to our original goal which assumed payments for Framework deals would be more front-end loaded. We now expect cash to be in the range of $22-25 million at year end.

SeaChange management continues to believe that achieving these goals will establish the foundation for a business model that could result in sustainable double-digit revenue growth and non-GAAP operating income growth of 12-15% in 2 to 3 years.

These GAAP estimates are subject to a number of variables that are outside of management’s control, including the size of restructuring expenses, which are influenced by the timing of certain non-U.S. restructuring activities and stock price fluctuations.

Conference Call

The Company will host a conference call to discuss its second quarter Fiscal 2020 results at 5:00 p.m. ET today, Thursday, August 29, 2019. The call may be accessed by dialing 877-407-8037 (U.S.) and 201-689-8037 (international) and via live webcast on the Events page at investors.seachange.com. The webcast replay will be archived the same location following completion of the call.

About SeaChange International

SeaChange is a leading supplier of Video Delivery Software Solutions. Our solution powers hundreds of cloud and on-premise video delivery platforms, servicing over 50 million subscribers worldwide. SeaChange offers value-based engagement which provides content and service providers with a complete software delivery platform for linear, VOD and TSTV over managed and unmanaged networks. The SeaChange Framework solution includes video back-office, media asset management, targeted advertising management, analytics and the client interface for STBs, Smart-TVs and mobile devices. Our solution is available as a product or managed service deployed on-premises, in the cloud or as a hybrid. For more information, please visit www.seachange.com.

Safe Harbor Provision

Any statements contained in this press release that do not describe historical facts, including the impact changes currently underway, our framework video delivery model, the share repurchase authorization, the anticipated closing of deals, revenue, gross margins, development of new product offerings, cost savings, income from operations, cash balance and other financial matters, are neither promises nor guarantees and may constitute “forward-looking statements” as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include words such as “may,” “might,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “seeks,” “intends,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. Any such forward-looking statements contained herein are based on current assumptions, estimates and expectations, but are subject to a number of known and unknown risks and significant business, economic and competitive uncertainties that may cause actual results to differ materially from expectations. Numerous factors could cause actual future results to differ materially from current expectations expressed or implied by such forward-looking statements, including, without limitation, the following: the continued spending by the Company’s customers on video solutions and services and expenses we may incur in fulfilling customer arrangements; the success of our efforts to introduce SaaS-based multiscreen service offerings; the Company’s ability to successfully introduce new products or enhancements to existing products; the manner in which the multiscreen video and OTT markets develop; the Company’s transition to being a company that primarily provides software solutions; the Company’s ability to compete in the marketplace; any failure by the Company to respond to changing technology; measures taken to address the variability in the market for our products and services; the loss of or reduction in demand, or the return of product, by one of the Company’s large customers or the failure of revenue acceptance criteria in a given fiscal quarter; consolidation in the markets the Company serves; the cancellation or deferral of purchases of the Company’s products; the adoption of our value-based selling approach; the length of the Company’s sales cycles; any decline in demand or average selling prices for our products and services; failure to manage product transitions; failure to achieve our financial forecasts due to inaccurate sales forecasts or other factors, including due to expenses we may incur in fulfilling customer arrangements; the impact of restructuring programs; the Company’s ability to manage its growth; the risks associated with international operations; foreign currency fluctuation; the Company’s ability to protect its intellectual property rights and the expenses that may be incurred by the Company to protect its intellectual property rights; an unfavorable result of current or future litigation relating to the Company’s intellectual property; content providers limiting the scope of content licensed for use in the video-on-demand and OTT market or other limitations in materials we use to provide our products and services; the Company’s ability to realize the benefits of completed or future acquisitions, including Xstream A/S; the impact of acquisitions, divestitures or investments made by the Company; the Company’s ability to raise additional funds through capital markets on favorable terms and in a timely manner; the Company’s ability to access sufficient funding to finance desired growth and operations; any impairment of the Company’s assets; the ability of the Company to use its net operating losses; the Company’s ability to hire and retain highly skilled employees; the ability of the Company to manage and oversee the outsourcing of engineering work; additional tax liabilities to which the Company may be subject, including should the Company’s net operating loss carry-forwards be impaired, notwithstanding the Company’s Tax Benefits Preservation Plan; possible adjustments to estimates resulting from the new tax legislation; any breach of the Company’s security measures and customer data or our data being obtained unlawfully; evolving data privacy regulations; service interruptions or delays from our third-party data center hosting facilities; disruptions to the Company’s information technology systems; stock price volatility and compliance with Nasdaq continued listing standards; actions that may be taken by significant stockholders, notwithstanding the February 2019 Cooperation Agreement with TAR Holdings LLC; if securities analysts do not publish favorable research or reports about our business; our use of non-GAAP reporting; change in accounting standards; any weakness in the Company’s internal controls over financial reporting; the Company’s use of estimates in accounting for the Company’s contracts; the performance of the Company’s third-party vendors; the Company’s entry into fixed price contracts and the related risk of cost overruns; the risks associated with purchasing material components from sole suppliers and using a limited number of third-party manufacturers; the performance of companies in which the Company has made investments; the impact of changes in the market on the value of our investments; changes in the regulatory environment; uncertainties of regulation of the Internet and data traveling over the Internet; the ability of the Company and its intermediaries to comply with the Foreign Corrupt Practices Act; terrorist acts, conflicts, wars and geopolitical uncertainties; and the Company’s Delaware anti-takeover provisions. These risks and other risk factors that could cause actual results to differ from those anticipated are detailed in various publicly available documents filed by the Company from time to time with the Securities and Exchange Commission (SEC), which are available at www.sec.gov, including but not limited to, such information appearing under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the SEC on April 12, 2019. Any forward-looking statements should be considered in light of those risk factors. The Company cautions readers not to rely on any such forward-looking statements, which speak only as of the date they are made. The Company disclaims any intent or obligation to publicly update or revise any such forward-looking statements to reflect any change in Company expectations or future events, conditions or circumstances on which any such forward-looking statements may be based, or that may affect the likelihood that actual results may differ from those set forth in such forward-looking statements.

Contact:

Investors
Mary T. Conway
Conway Communications
1-781-772-1679
mary.conway@schange.com

TABLES TO FOLLOW

SeaChange International, Inc.
Preliminary Condensed Consolidated Balance Sheets
(Unaudited, amounts in thousands)

July 31,
2019

January 31, 2019

Assets

Cash and cash equivalents

$
9,202

$
20,317

Marketable securities

9,589

10,359

Accounts and other receivables, net

11,019

19,267

Unbilled receivables

9,002

5,448

Inventories, net

198

924

Prepaid expenses and other current assets

6,087

6,033

Property and equipment, net

6,888

7,192

Goodwill and intangible assets, net

12,760

8,753

Unbilled receivables, long-term

3,066

Other assets

2,381

450

Total assets

$
70,192

$
78,743

Liabilities and Stockholders’ Equity

Accounts payable and other liabilities

$
14,203

$
12,265

Deferred revenues

9,156

10,746

Deferred tax liabilities and income taxes payable

418

632

Total liabilities

23,777

23,643

Total stockholders’ equity

46,415

55,100

Total liabilities and stockholders’ equity

$
70,192

$
78,743

SeaChange International, Inc.
Preliminary Condensed Consolidated Statements of Operations
(Unaudited, amounts in thousands, except per share data)

For the Three Months

Ended July 31,

For the Six Months

Ended July 31,

2019

2018

2019

2018

Revenue:

Product

$
11,968

$
1,462

$
13,147

$
4,553

Service

6,844

10,439

14,150

22,283

Total revenue

18,812

11,901

27,297

26,836

Cost of revenue:

Product

3,039

490

3,948

816

Service

4,885

5,125

9,553

10,828

Total cost of revenue

7,924

5,615

13,501

11,644

Gross profit

10,888

6,286

13,796

15,192

Operating expenses:

Research and development

3,775

5,185

8,027

10,914

Selling and marketing

2,963

3,932

5,815

7,599

General and administrative

4,150

4,903

8,399

9,475

Severance and restructuring costs

659

536

870

590

Total operating expenses

11,547

14,556

23,111

28,578

Loss from operations

(659
)

(8,270
)

(9,315
)

(13,386
)

Other expense, net

(78
)

(1,962
)

(1,869
)

(2,811
)

Loss before income taxes

(737
)

(10,232
)

(11,184
)

(16,197
)

Income tax benefit

(563
)

(1,152
)

(161
)

(1,646
)

Net loss

$
(174
)

$
(9,080
)

$
(11,023
)

$
(14,551
)

Net loss per share, basic and diluted

$

$
(0.26
)

$
(0.30
)

$
(0.41
)

Weighted average common shares outstanding, basic and diluted

36,602

35,649

36,532

35,628

SeaChange International, Inc.
Preliminary Condensed Consolidated Statements of Cash Flows
(Unaudited, amounts in thousands)

For the Six Months

Ended July 31,

2019

2018

Cash flows from operating activities:

Net loss

$
(11,023
)

$
(14,551
)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization expense

1,093

1,552

Provision for bad debts

388

Stock-based compensation expense

197

1,802

Deferred income taxes

(203
)

(758
)

Unrealized foreign currency transaction gain

1,340

1,431

Other

67

76

Changes in operating assets and liabilities, including impact of

acquisitions:

Accounts receivable

8,482

10,115

Unbilled receivables

(6,598
)

(2,335
)

Inventory

726

(165
)

Prepaid expenses and other current assets and other assets

196

(1,584
)

Accounts payable

1,350

371

Accrued expenses and other liabilities

(2,463
)

(10,640
)

Deferred revenue

(1,590
)

(5,729
)

Other operating activities

2,430

Net cash used in operating activities

(8,038
)

(17,985
)

Cash flows from investing activities:

Purchases of property and equipment

(153
)

(284
)

Cash paid for acquisitions, net

(3,838
)

Purchases of marketable securities

(823
)

(4,354
)

Proceeds from sales and maturities of marketable securities

1,593

2,761

Other investing activities

(60
)

Net cash used in investing activities

(3,221
)

(1,937
)

Cash flows from financing activities:

Proceeds from issuance of common stock

9

74

Repurchases of common stock

(142
)

Other financing activities

(35
)

Net cash (used in) provided by financing activities

(133
)

39

Effect of exchange rate on cash and cash equivalents

277

1,162

Net decrease in cash, cash equivalents and restricted cash

(11,115
)

(18,721
)

Cash, cash equivalents and restricted cash at beginning of period

20,317

43,661

Cash, cash equivalents and restricted cash at end of period

$
9,202

$
24,940

Supplemental disclosure of cash flow information

Income taxes paid

$
76

$
2,735

Non-cash activities:

Purchases of property and equipment included in accounts payable

$
58

$

Fair value of common stock issued in acquisition

$
874

$

Non-GAAP Measures

We define non-GAAP loss from operations as U.S. GAAP operating loss plus stock-based compensation expenses, amortization of intangible assets, non-operating expense professional fees and severance and other restructuring costs. We discuss non-GAAP loss from operations in our quarterly earnings releases and certain other communications, as we believe non-GAAP operating loss from operations is an important measure that is not calculated according to U.S. GAAP. We use non-GAAP loss from operations in internal forecasts and models when establishing internal operating budgets, supplementing the financial results and forecasts reported to our Board of Directors, determining a component of bonus compensation for executive officers and other key employees based on operating performance and evaluating short-term and long-term operating trends in our operations. We believe that the non-GAAP loss from operations financial measure assists in providing an enhanced understanding of our underlying operational measures to manage the business, to evaluate performance compared to prior periods and the marketplace, and to establish operational goals. We believe that the non-GAAP financial adjustments are useful to investors because they allow investors to evaluate the effectiveness of the methodology and information used by management in our financial and operational decision-making.

Non-GAAP loss from operations is a non-GAAP financial measure and should not be considered in isolation or as a substitute for financial information provided in accordance with U.S. GAAP. This non-GAAP financial measure may not be computed in the same manner as similarly titled measures used by other companies. We expect to continue to incur expenses similar to the financial adjustments described above in arriving at non-GAAP loss from operations and investors should not infer from our presentation of this non-GAAP financial measure that these costs are unusual, infrequent or non-recurring. The following table includes the reconciliations of our U.S. GAAP loss from operations, the most directly comparable U.S. GAAP financial measure, to our non-GAAP loss from operations for the three and six months ended July 31, 2019 and 2018:

SeaChange International, Inc.
Fiscal Year Reconciliation of GAAP to Non-GAAP
(Unaudited, amounts in thousands, except per share and percentage data)

For the Three Months

Ended July 31,

2019

2018

(Amounts in thousands)

GAAP loss from operations

$
(659
)

$
(8,270
)

Amortization of intangible assets

299

411

Stock-based compensation

631

923

Professional fees – other

61

Severance and other restructuring costs

659

536

Non-GAAP income (loss) from operations

$
991

$
(6,400
)

Net income (loss) per share per non-GAAP income (loss) from operations, basic and diluted

$
0.03

$
(0.18
)

Weighted average common shares outstanding, basic and diluted

36,602

35,649

SeaChange International, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited, amounts in thousands, except per share data)

Twelve Months Ended

January 31, 2020

GAAP revenue guidance

$
70,000

to

$
80,000

GAAP income (loss) from operations per basic share

(0.09
)

0.07

Exclude stock compensation expense

0.07

0.07

Exclude amortization of intangible assets

0.02

0.02

Exclude professional fees associated with divestitures

0.01

0.01

Exclude restructuring costs

0.02

0.02

Non-GAAP income from operations per diluted or basic shares

$
0.03

$
0.19

SeaChange International, Inc.
Supplemental Schedule – Revenue Breakout
(Unaudited, amounts in thousands)

Three Months Ended July 31,

Six Months Ended July 31,

2019

2018

2019

2018

(Amounts in thousands)

(Amounts in thousands)

Product revenues:

Framework

$
8,244

$

$
8,244

$

Video platform

11

524

168

3,339

OVP

811

1,566

Advertising

545

609

724

609

User experience

7

24

Hardware

2,357

322

2,445

581

Total product revenues

11,968

1,462

13,147

4,553

Service revenues:

Maintenance and support

4,999

7,017

10,238

14,239

Framework and support services

109

109

SaaS

223

63

426

193

Professional services – video platform

1,513

3,359

3,377

7,730

User experience

121

Total service revenues

6,844

10,439

14,150

22,283

Total revenues

$
18,812

$
11,901

$
27,297

$
26,836

SOURCE: SeaChange International, Inc.

ReleaseID: 557891

Pro-Dex, Inc. Announces Fiscal 2019 Fourth Quarter And Full-Year Results

IRVINE, CA, / ACCESSWIRE / August 29, 2019 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2019 fourth quarter and full-year ended June 30, 2019.

Quarter Ended June 30, 2019

Net sales for the three months ended June 30, 2019 increased $756,000, or 12%, to $7.0 million from $6.2 million for the three months ended June 30, 2018, due primarily to increased medical device sales and repair revenue generated from our largest customer of a product used in orthopedic surgical applications. Gross profit for the three months ended June 30, 2019 increased $153,000, or 6%, to $2.5 million from $2.4 million for the same period in 2018. The increase in gross margin is due to better absorption of our fixed costs due to higher sales volumes, as well as manufacturing efficiencies derived this fiscal year from higher volumes and continued investment in new machinery.

Operating expenses (which include selling, general and administrative, and research and development expenses) for the quarter ended June 30, 2019 decreased 27% to $1.4 million from $1.9 million in the prior year’s corresponding quarter, due primarily to the prior year impairment of our entire $800,000 investment in Monogram Orthopaedics Inc. (“Monogram”) offset by increased expenditures of $61,000 in selling expenses and $97,000 in research and development costs to support our continued efforts to further grow our business, as well as an increase of $148,000 in general and administrative expenses due to increased bonus accruals.

Net income for the quarter ended June 30, 2019 increased by $720,000, to $888,000, or $0.21 per diluted share, compared to $168,000, or $0.04 per diluted share, in the corresponding quarter in 2018.

Year Ended June 30, 2019

Net sales for the fiscal year ended June 30, 2019 increased $4.7 million, or 21%, to $27.2 million from $22.5 million for the fiscal year ended June 30, 2018, due primarily to increases in medical device revenues. Specifically, our largest customer accounted for an increase of $4.6 million in revenue during fiscal 2019.

Gross profit for the fiscal year ended June 30, 2019 increased $1.8 million, or 23%, to $9.8 million compared to $7.9 million for fiscal 2018, due to increased revenues and manufacturing efficiencies.

Operating expenses (which include selling, general and administrative, and research and development expenses) for the fiscal year ended June 30, 2019 decreased 14% to $4.8 million from $5.6 million in the prior fiscal year, due in part to the prior year impairment charges related to our Monogram investment as well as our Fineline Molds division, which we sold in May 2018.

Net income for the fiscal year ended June 30, 2019 was $4.2 million, or $0.97 per diluted share, compared to $1.6 million, or $0.37 per diluted share, for fiscal 2018.

Although the Company has released its earnings prior to the filing of its annual Form 10-K with the Securities and Exchange Commission, we are able to do this because we are a non-accelerated filer and as a result have more time to do so at fiscal year-end. During our quarterly reporting periods we anticipate that our earnings releases will continue to be released at the same time as our Form 10-Q’s are filed with the Securities and Exchange Commission. We anticipate filing our Form 10-K with the Securities and Exchange Commission on September 12, 2019.

CEO Comments

Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer, commented, “We are pleased with our fiscal 2019 results, especially our fourth quarter sales which is a record for the Company. We will focus our fiscal 2020 efforts on additional organic sales growth and continue our efforts to pursue our product roadmap.”

About Pro-Dex, Inc.:

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers used primarily in the orthopedic, spine, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. Pro-Dex also sells rotary air motors. Pro-Dex’s products are found in hospitals and medical engineering labs around the world. For more information, visit the Company’s website at www.pro-dex.com.

Statements herein concerning the Company’s plans, growth and strategies may include “forward-looking statements” within the context of the federal securities laws. Statements regarding the Company’s future events, developments and future performance, as well as management’s expectations, beliefs, plans, estimates, or projections relating to the future are forward-looking statements within the meaning of these laws. The Company’s actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company’s filings with the Securities and Exchange Commission.

(tables follow)

PRO-DEX, INC.
BALANCE SHEETS
In thousands, except share data)

June 30,

2019

2018

ASSETS

Current assets:

Cash and cash equivalents

$
7,742

$
5,188

Investments

2,649

2,220

Accounts receivable, net of allowance for doubtful accounts of $0 and $14 at June 30, 2019 and 2018, respectively.

4,100

2,955

Deferred costs

430

32

Notes receivable

1,176

Inventory

6,239

4,393

Prepaid expenses and other current assets

623

269

Total current assets

21,783

16,233

Plant, equipment and leasehold improvements, net

2,726

1,755

Intangibles, net

129

140

Deferred income taxes, net

260

1,678

Investments

582

Notes receivable, net of current portion

43

Other assets

40

68

Total assets

$
25,520

$
19,917

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$
1,996

$
1,083

Accrued liabilities

1,437

1,266

Deferred revenue

215

31

Note payable and capital lease obligations

622

35

Total current liabilities

4,270

2,415

Non-current liabilities:

Deferred rent

146

97

Income taxes payable

162

123

Notes and capital lease payable, net of current portion

3,934

6

Total non-current liabilities

4,242

226

Total liabilities

8,512

2,641

Commitments and Contingencies:

Shareholders’ equity:

Common stock, no par value, 50,000,000 shares authorized; 4,039,491 and 4,331,089 shares issued and outstanding at June 30, 2019 and 2018, respectively

15,815

19,835

Accumulated other comprehensive loss

(549
)

(153
)

Retained earnings (accumulated deficit)

1,742

(2,406
)

Total shareholders’ equity

17,008

17,276

Total liabilities and shareholders’ equity

$
25,520

$
19,917

PRO-DEX, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)

Three Months Ended
June 30,

(Unaudited)

Years Ended
June 30,

2019

2018

2019

2018

Net sales

$
7,003

$
6,247

$
27,172

$
22,465

Cost of sales

4,461

3,858

17,392

14,522

Gross profit

2,542

2,389

9,780

7,943

Operating (income) expenses:

Selling expenses

162

101

415

358

General and administrative expenses

654

506

2,492

2,287

Asset impairment charges

800

1,029

Gain from disposal of equipment

(7
)

(16
)

Research and development costs

545

448

1,882

1,893

Total operating expenses

1,361

1,855

4,782

5,551

Operating profit

1,181

534

4,998

2,392

Interest expense

(65
)

(1
)

(220
)

(7
)

Other income

10

45

Gain in sale of investments

356

Interest and dividend income

42

59

268

225

Income before income taxes

1,168

592

5,447

2,610

Income tax expense

280

424

1,299

989

Net income

$
888

$
168

$
4,148

$
1,621

Basic & Diluted income per share:

Basic net income per share

$
0.22

$
0.04

$
0.99

$
0.38

Diluted net income per share

$
0.21

$
0.04

$
0.97

$
0.37

Weighted average shares outstanding:

Basic

4,098,450

4,349,487

4,192,365

4,304,602

Diluted

4,204,365

4,389,268

4,298,332

4,344,765

PRO-DEX, INC.
STATEMENTS OF CASH FLOWS
(In thousands)

Years Ended June 30,

2019

2018

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

$
4,148

$
1,621

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

438

557

Gain on sale of investments

(356
)

Gain on sale or disposal of equipment

(7
)

(16
)

Amortization of loan fees

7

Asset impairment charges

1,029

Share-based compensation

37

194

Deferred income taxes

1,418

391

Bad debt expense (recovery)

(14
)

14

Changes in operating assets and liabilities:

Accounts receivable

(1,131
)

569

Deferred costs

(398
)

(19
)

Assets held for sale

31

Inventory

(1,846
)

(1,309
)

Prepaid expenses and other assets

(326
)

(45
)

Accounts payable, accrued expenses and deferred rent

1,133

(57
)

Deferred revenue

184

13

Income taxes payable

39

123

Net cash provided by operating activities

3,326

3,096

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of equipment and leasehold improvements

(1,387
)

(923
)

Purchase of notes receivable

(350
)

Investment in Loan Participation

(1,150
)

Proceeds from dividend reclassified as return of principal

23

Proceeds from sale of equipment

7

30

Proceeds from collection of notes receivable

1,219

Proceeds from sale of investments

1,905

Increase in intangibles

(11
)

(11
)

Purchase of investments

(2,978
)

(1,711
)

Net cash used in investing activities

(1,222
)

(4,115
)

CASH FLOWS FROM FINANCING ACTIVITIES:

Principal payments on capital lease and note payable

(433
)

(78
)

Proceeds from shares issued under ATM

2,262

Borrowing from Minnesota Bank & Trust, net of loan origination fees

4,940

Repurchases of common stock

(3,984
)

(220
)

Payments of employee taxes on net issuance of common stock

(101
)

Proceeds from exercise of stock options and ESPP contributions

28

38

Net cash provided by financing activities

450

2,002

Net increase in cash and cash equivalents

2,554

983

Cash and cash equivalents, beginning of year

5,188

4,205

Cash and cash equivalents, end of year

$
7,742

$
5,188

Contact:

Richard L. Van Kirk, Chief Executive Officer
(949) 769-3200

SOURCE: Pro-Dex, Inc.

ReleaseID: 557781

Nevada’s 155th Birthday: Extraterrestrials, Burners, Ghost-Hunters, Foodies & Mountaineers Invited

EDITORS: Downloadable high-resolution photos here.

CARSON CITY, NV / ACCESSWIRE / August 29, 2019 Nevada celebrates its 155th birthday this fall with ghost hunts, extraterrestrial alien fun, quirky festivals and an open call for self-expression and exploration. A hub for Western history, road trips and paranormal activity, Nevada offers fall experiences that will leave visitors covered in dust, sauce, feathers or white as a ghost.

Stormers vs. Burners

Would you rather see a spacecraft or drive an art car? If you’re thinking of storming Area 51 or getting dusty at Burning Man this September, pack water and hit the road. While you can’t visit Area 51 – the military base at the heart of the Storm Area 51 Facebook event that recently went viral – you can drive Nevada’s Extraterrestrial Highway. If radical self-expression is more your vibe, but you didn’t get tickets for the annual Burning Man festival, consider driving the Burner Byway out to the Black Rock Desert later this fall. Stay at the Morris Burner Hostel in Reno; tour The Generator, a maker space where many of the large-scale sculptures exhibited at Burning Man are created; and check out Burning Man art displayed at the Playa Art Park and other locations throughout the city.

The party’s in Nevada

Nevada’s sometimes quirky, always fun special events more than justify a trip to the Silver State. Watch planes race in the skies above Reno at the National Championship Air Races Sept. 11-15; cheer on engineers as they attempt to break records at the World Human Powered Speed Challenge, Sept. 8-14 in Battle Mountain or check out mural art at the brand-new Elko Mural Festival, Sept. 26-29. October brings the Park to Pedal bike event in Lincoln County (Oct. 12); the Tim Burton exhibit to the Neon Museum in Las Vegas (debuts Oct. 15); and the blowout Nevada Day festivities in Carson City (Oct. 25).

Investigate the paranormal

The Silver State has its share of supernatural sites, if you’re up for a Halloween-themed visit. The old mining town of Virginia City celebrates its status as one of the most haunted towns in the country with Hauntober, a string of ghost tours and events throughout October. In the heart of Nevada, the town of Tonopah is home to the haunted Mizpah Hotel, where the Lady in Red ghost supposedly haunts guests on the fifth floor. On the southern end of the state, hunt for ghosts at the Pioneer Saloon in Goodsprings, about 35 miles southwest of Las Vegas. Here, you can take the Haunted Lockdown Tour, an overnight stay at this scary site, once featured in an episode of “Ghost Adventures” TV show.

Savor the food fests

A Nevada trip can be delicious, especially if it includes one of the many culinary celebrations happening this fall. The annual Genoa Candy Dance celebrates 100th years this September: the community fundraiser, created in 1919 to pay for the town’s street lights, has music, arts and crafts, and of course, plenty of chocolate. In southern Nevada, the Las Vegas Food and Wine Festival, Oct. 3-6, attracts nearly 50 renowned celebrity chefs, including Chef Charlie Palmer, to the Italian-inspired Tivoli Village in Vegas, and for those with adventurous palates, there is the Disgusting Food Museum, part of the Vegas Food Expo Oct. 8-10. Roasted guinea pig and maggot-infested cheese are some of the offerings. On the northern end of the state, Southern Fare on the Square takes place Oct. 5-6 in Sparks, followed by the Eldorado Great Italian Festival Oct. 12-13 in Reno.

Leaf peeping and mountain vistas

As the most mountainous state in the lower 48, Nevada has plenty of highland trails for leaf peepers and hikers. In northern Nevada, there’s Lamoille Canyon, a glacier-carved ravine in the Ruby Mountains near Elko; and Mount Rose summit in the Sierra Nevada near Reno. Great Basin National Park, on the eastern end of the state, is home to both Wheeler Peak, the state’s second tallest mountain at 13,064 feet; and the Lehman Caves. Just north of Las Vegas is Spring Mountain National Recreation Area, where Mount Charleston, at 11,916 feet, offers a challenge.

About Travel Nevada

The Nevada Division of Tourism (Travel Nevada) is part of the Nevada Department of Tourism and Cultural Affairs. It promotes and markets Nevada as a tourism destination for domestic and international leisure and business travelers through its marketing and advertising programs and by coordinating partnerships between public and private entities. TravelNevada also administers grant programs for local entities to market travel and tourism offerings and publishes Nevada Magazine.

CONTACT:

Travel Nevada
Bethany Drysdale, bdrysdale@travelnevada.com
Chris Moran, cmoran@travelnevada.com
775-687-0647

SOURCE: TravelNevada

ReleaseID: 557911

IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Just Energy Group Inc. and Encourages Investors with Losses In Excess of $50,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Just Energy Group Inc. (“Just Energy” or “the Company”) (NYSE:JE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between November 9, 2017 and July 23, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before September 30, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Just Energy suffered from both customer enrollment and nonpayment problems. The problems make it likely that the Company would be forced into an impairment charge to its accounts receivable. The Company also failed to maintain adequate internal controls over financial reporting. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Just Energy, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557921

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GTT Communications, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GTT Communications, Inc. (“GTT” or “the Company”) (NYSE:GTT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between February 26, 2018 and July 1, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before September 30, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. GTT experienced significant delays in integrating Interoute Communications Holdings S.A.’s (“Interoute”) systems and legacy processes into the Company’s client management database. Interoute had made selling cloud services a strategic priority, but a considerable percentage of Interoute sales reps were not able to effectively sell GTT’s cloud networking services. In fact, Interoute had allowed underperforming sales reps to remain on staff. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about GTT, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557920